NEW YORK, Nov. 14—Hurry up and wait: the biotech revolution, touted as the transformation that would speed sluggish drug development times and boost efficiency in the pharmaceutical industry, seems so far to have slowed the process down. The finding comes from a new study released Tuesday by the Tufts Center for the Study of Drug Development.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.